arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

GALECTIN THERAPEUTICS INC

GALT

$4.05 ▼ -0.11 (-2.64%) at close

17 Visible periods

19 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

GALECTIN THERAPEUTICS INC shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $258.8M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 12.4% ↘

FCF / Share $-0.37 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

17-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-30.84M

↑ +34.5% —

FCF / Share Free cash flow per share

$-0.37

↑ +44.3% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
EPS Growth YoY (%)	36.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-2.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-13.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-25.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-26.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	34.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-14.6% Weak ↑ Weak Improving Year-over-year change in net income	-5.9% Weak ↑ Weak Improving Year-over-year change in net income	-27.0% Weak ↑ Weak Improving Year-over-year change in net income	-30.1% Weak ↓ Weak Declining Year-over-year change in net income	-76.5% Weak ↓ Weak Declining Year-over-year change in net income	4.4% Caution ↓ Caution Declining Year-over-year change in net income	14.4% Fair ↑ Fair Improving Year-over-year change in net income	24.3% Good ↑ Good Improving Year-over-year change in net income	-7.0% Weak ↓ Weak Declining Year-over-year change in net income	-26.8% Weak ↑ Weak Improving Year-over-year change in net income	81.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-16.8% Weak ↑ Weak Improving Year-over-year change in net income	-559.6% Weak Weak Year-over-year change in net income	-93.9% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	44.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-22.3% Weak ↓ Weak Declining Year-over-year change in free cash flow	-4.8% Weak ↑ Weak Improving Year-over-year change in free cash flow	-25.9% Weak Weak Year-over-year change in free cash flow	-15.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
FCF / Net Income (x)	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.79x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Return on Invested Capital (%)	12.4% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	32.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	48.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	89.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-2669.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-82.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-207.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2421.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-164.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-87.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-57.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4627.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5061.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	387.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	227.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-102.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-242.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-135.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-180.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-72.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-79.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-151.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-390.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-136.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-76.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-52.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-809.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-780.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-157.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-77.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	24.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+61%)	44.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+199%)	66.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+342%)	114.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+662%)	—	-104.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-796%)	-30.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-302%)	-268.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1891%)	—	-208.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1489%)	-111.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-840%)	-74.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-597%)	—	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Interest Coverage (x)	—	—	-13.64x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-37.13x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-61.72x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-269.47x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-154.46x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-40.48x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1353.92x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-19.49x Weak Weak Operating income divided by interest expense Optimal: > 5x	-16.77x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-17.72M	$-15.12M	$-25.66M	$-18.59M	$-39.65M	$-27.14M	$-47.48M	$-8.25M	$-3.05M	$-15.36M	$-25.85M	$-29.13M	$-10.49M	$-9.36M	$-6.40M	$-5.89M	$-251.00K

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Basic EPS, GAAP (USD)	$-0.48	$-0.76	$-0.74	$-0.65	$-0.52	$-0.41	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.37	$-0.67	$-0.55	$-0.52	$-0.42	$-0.36	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-1.96	$-1.66	$-1.00	$-0.57	$0.02	$0.39	$0.77	$0.13	$-0.01	$0.31	$0.63	$0.95	$0.08	$0.07	$-0.16	$-0.16	—
Tangible Book Value per Share (USD)	$-1.96	$-1.66	$-1.00	$-0.57	$0.02	$0.39	$0.77	$0.13	$-0.01	$0.31	$0.63	$0.95	$0.08	$0.07	$-0.17	$-0.16	—
Basic Weighted Avg Shares (shares)	63.90M	62.31M	60.16M	59.39M	58.53M	57.03M	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Working Capital (USD)	$11.41M	$-18.16M	$12.03M	$7.54M	$32.79M	$24.07M	$45.39M	$6.72M	$851.00K	$12.01M	$25.04M	$27.96M	$8.20M	$7.88M	$4.29M	$4.42M	—
Total Equity (USD)	$-127.92M	$-104.79M	$-61.96M	$-33.92M	$893.00K	$22.47M	$43.87M	$5.17M	$-530.00K	$10.29M	$18.04M	$21.20M	$1.48M	$1.17M	$-2.12M	$-1.69M	$-4.47M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Depreciation Expense (USD)	—	—	—	—	—	—	—	$0.00	$1.00K	$7.00K	$7.00K	$10.00K	$567.00K	$3.00K	$6.00K	—	—
Net Income, GAAP (USD)	$-30.84M	$-47.05M	$-41.07M	$-38.78M	$-30.53M	$-23.46M	$-13.29M	$-13.90M	$-16.23M	$-21.44M	$-20.03M	$-15.79M	$-84.08M	$-71.99M	$-10.91M	$-5.63M	—
Operating Cash Flow (USD)	$-23.88M	$-41.77M	$-32.97M	$-31.06M	$-24.31M	$-20.60M	$-10.85M	$-10.18M	$-15.89M	—	—	—	$-66.04M	$-58.55M	$-5.68M	$-3.10M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 67 quarters

GALECTIN THERAPEUTICS INC

Analytical Summary

17-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare GALT with peers